Sales decline 31.61% to Rs 10.86 crore
Net profit of Bafna Pharmaceuticals reported to Rs 28.09 crore in the quarter ended December 2017 as against net loss of Rs 3.44 crore during the previous quarter ended December 2016.Sales declined 31.61% to Rs 10.86 crore in the quarter ended December 2017 as against Rs 15.88 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales10.8615.88 -32 OPM %5.06-0.76 -PBDT29.08-2.47 LP PBT28.09-3.49 LP NP28.09-3.44 LP
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)